Literature DB >> 31219944

Maxillary Sinusitis Associated With Peri-implantitis at Sinus Floor Augmented Sites: Case Series.

Won-Bae Park1, Ji-Young Han2, Se-Lim Oh3.   

Abstract

PURPOSE: The purpose of this case series was to investigate treatment outcomes of maxillary sinusitis associated with peri-implantitis at sinus floor augmented sites for a 3-year follow-up.
MATERIALS AND METHODS: Eighteen implants in 8 patients diagnosed with maxillary sinusitis associated with peri-implantitis were reviewed. Four patients were treated with implant removal and antibiotics, and 4 patients were treated with implant removal, the modified Caldwell-Luc operation (CLOP), and antibiotics. Seven patients, who had 7 survived implants, were followed up to 3 years after treatment. The characteristics between failed and survived implants were compared. Radiographic parameters of survived implants were analyzed using the Friedman test.
RESULTS: Eleven failed implants from 8 patients exhibited approximately 10-mm pocket depths and mobility at diagnosis. Seven survived implants from 7 patients exhibited no significant changes in crestal bone loss at the facial side for 3 years after the treatments. Sinus mucosal thickening was significantly reduced during the 3-year follow-up after the treatments.
CONCLUSION: The progression of peri-implantitis in sinus floor augmented sites may lead to maxillary sinusitis. To confirm the efficacy of the intraoral approaches, such as the modified CLOP, systematic clinical studies with a large sample size and a long-term follow-up should be conducted.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31219944     DOI: 10.1097/ID.0000000000000922

Source DB:  PubMed          Journal:  Implant Dent        ISSN: 1056-6163            Impact factor:   2.454


  1 in total

Review 1.  A review of rare complications of maxillary sinus floor augmentation.

Authors:  Sung Woon On; Seoung-Won Cho; Byoung-Eun Yang
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-12-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.